文献速递肝病消化道肿瘤与早癌

重编程巨噬细胞以治疗肝病

Reprogramming macrophages to treat liver diseases.
PubMed 文献 · Hepatology · 2024-11-12

综述指出,单细胞与空间转录组学揭示肝病中巨噬细胞高度异质且功能多样,促炎与抗炎亚群可共存于邻近区域。循环可溶性标志物仅部分反映这种复杂性,重编程巨噬细胞需理解多重调控机制并设计靶向干预以恢复肝脏稳态,纳米级治疗是潜在方向。

要点

  • 肝病中巨噬细胞活化程序高度异质,促炎与抗炎亚群可共存于肝脏邻近区域。
  • 循环可溶性炎症标志物仅部分反映肝脏巨噬细胞亚群的完整复杂性。
  • 重编程巨噬细胞需理解多重调控机制并设计靶向干预,纳米级治疗为潜在方向。

核心结论

  • 综述总结慢性肝炎、肝硬化和肝细胞癌中激活的多样巨噬细胞程序,认为其可能对精准医学具有治疗意义。

研究设计与样本

  • 综述,总结单细胞与空间转录组学研究及肝病巨噬细胞浸润与极化状态的临床数据。

主要发现

  • 临床数据中巨噬细胞浸润和极化状态有助于预测肝硬化及/或肝细胞癌患者的死亡或不良预后。
  • 单细胞与空间转录组学揭示巨噬细胞高度异质,并在促进和消退肝脏炎症、损伤和纤维化中具有多重作用。
  • 肝脏巨噬细胞(驻留组织库普弗细胞和单核细胞来源巨噬细胞)可塑性和表型多样性高,功能拮抗的巨噬细胞可共存于肝脏邻近区域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cutting-edge research has expanded our understanding of the macrophage activation programs in liver diseases making this immune cell type a therapeutic target. Clinical data on macrophage infiltration and polarization states have been used to help predict mortality or poor prognosis in patients with liver cirrhosis and/or HCC. The latest single-cell and spatial transcriptomics studies have dissected unforeseen aspects depicting the immense heterogeneity of macrophages and their multifaceted role in both promoting and resolving hepatic inflammation, injury, and fibrosis. Hepatic macrophages (resident tissue KCs and monocyte-derived macrophages) display such plasticity and phenotypic diversity that macrophages with antagonistic functions may coexist in adjacent regions of the liver. In this scenario, the analysis of macrophage-derived inflammatory and anti-inflammatory circulating soluble markers in patients with liver disease only offers a partial picture of the full complexity of the hepatic macrophage subsets. The reprogramming of macrophages involves understanding the multiple regulatory mechanisms and diverse populations of hepatic macrophages and the design of macrophage-targeted therapeutic interventions to restore hepatic homeostasis. Here we review the potential targets to modulate macrophage behavior in liver diseases and nanoscale therapeutics that aim to target and treat macrophages. We will summarize current knowledge on the diverse macrophage programs activated in chronic liver inflammation, cirrhosis, and HCC that may be of therapeutic interest for precision medicine.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Simón-Codina B, Cacho-Pujol J, Moles A, et al. Reprogramming macrophages to treat liver diseases. Hepatology. 2024. PMID: 39716928. doi:10.1097/HEP.0000000000001160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。